Stocks Explorer
Stocks
Sectors
Search
Redhill Biopharma Ltd.(RDHL) News
Profile
Chart
News
Analysis
Holders
RDHL price today
by TradingView
Date
Title
Dec 4
RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
Nov 27
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034
May 22
RedHill Provides R&D Update
‹ Prev
Page
of 2
Next ›